Should measurement of ApoB/ApoA1 ratio be incorporated into clinical guidelines?

The ratio of apolipoprotein B/apolipoprotein A-I (i.e., atherogenic to atheroprotective lipoproteins) was the strongest predictor of cardiovascular risk, according to pooled analyses of two recent major statin studies, presented at the American Heart Association Scientific Sessions.

Download Attachment